πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 369 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7728004

Crystalline form of a quinolinone-carboxamide compound

Theravance, Inc. Β· Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7723470

Glycopeptide derivatives and pharmaceutical compositions containing the same

Theravance, Inc. Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7713931

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7700550

Glycopeptide phosphonate derivatives

Theravance, Inc. Β· Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7700777

Crystalline forms of a biphenyl compound

Theravance, Inc. Β· Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7691878

Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance, Inc. Β· Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7687521

Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor a

Theravance, Inc. Β· Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7687519

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7683173

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7674908

Indazole-carboxamide compounds as 5-HT4 receptor agonists

Theravance, Inc. Β· Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7671198

Process for preparing intermediates to 5-HT4 receptor agonist compounds

Theravance, Inc. Β· Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662815

Diaryl ether Ξ²2 adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7659403

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655621

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7649080

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7642355

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Jan 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7638639

Substituted pyrrolidine and related compounds

Theravance, Inc. Β· Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7632847

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7629336

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. Β· Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622587

Crystalline form of a benzimidazole-carboxamide medicinal compound

Theravance, Inc. Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622508

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance, Inc. Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622467

Aryl aniline derivatives as Ξ²2 adrenergic receptor agonists

Theravance, Inc. Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7615566

Substituted pyrrolidine and related compounds

Theravance, Inc. Β· Granted Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7612037

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. Β· Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted